I might be stating the obvious, but if the BOT team has a copy of the FDA mid-cycle review letter outlining the scheduled points to be discussed during the phone call to take place, then I’d say there’s a pretty good chance BOT management currently have a strong indication of how positive the mid-cycle review will be.
I’m wondering if the tweet from BOT today is a sign that the mid-cycle review will be positive, or why draw attention to a mid-cycle review expected to be negative?
BOT - Anything but charting, page-4063
-
- There are more pages in this discussion • 5,417 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.8¢ |
Change
-0.008(2.00%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.5¢ | $701.8K | 1.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 558973 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 318337 | 11 |
View Market Depth
| Last trade - 11.36am 30/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |